Overview

Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis

Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
To investigate that olanzapine can reduced side effect about nausea and vomiting in women with gynecologic cancers receiving carboplatin-based regimen by using olanzapine and placebo
Phase:
Phase 3
Details
Lead Sponsor:
Rajavithi Hospital
Treatments:
Carboplatin
Olanzapine